相关实验视频

Updated: Sep 10, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

在子宫癌中诱导PI3K激活

Kirsten Kübler^1,2,3,4,5,6, Agostina Nardone⁷, Shankara Anand⁸

¹Broad Institute of MIT and Harvard, Cambridge, MA, USA. kirsten.kuebler@bih-charite.de.

Nature genetics

|August 22, 2025

概括

泰莫西芬治疗很少引起子宫癌症,但遗传原因尚不清楚. 这项研究显示,他莫西芬激活了关键的癌症途径,作为子宫瘤发展的非遗传驱动因素.

科学领域:

癌症学
分子生物学
癌症研究

背景情况:

治疗相关的二次瘤是已知的癌症治疗并发症.
纳莫西芬治疗与二次子宫癌有关,但潜在的遗传机制尚不清楚.

研究的目的:

研究因他莫西芬而导致子宫瘤的遗传机制.
探索PIK3CA突变和PI3K信号在与他莫西芬相关的子宫癌中的作用.

主要方法:

在与他莫西芬相关的子宫癌与新发的子宫癌中对PIK3CA突变频率进行比较分析.
使用小鼠模型进行体内研究以评估泰莫西芬诱导的雌激素受体刺激和子宫组织中的PI3K信号激活.

主要成果:

与新生子宫癌相比,与他莫西芬相关的子宫瘤中发生的瘤性PIK3CA突变明显较少.
泰莫西芬诱导的雌激素受体激活了正常小鼠子宫组织中的酸3-激酶 (PI3K) 信号.

结论:

泰莫西芬诱导的PI3K通路激活是子宫致癌的非遗传驱动事件.
这种PI3K通路激活可能会消除与他莫西芬相关的子宫癌中PI3K激活突变的选择性优势.
治疗诱导的信号事件的概念可能广泛适用于其他类型的瘤发生.

更多相关视频

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...